Payments to Acquire Property, Plant, and Equipment of Protara Therapeutics, Inc. from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Protara Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • Protara Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $44,000.
  • Protara Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $94,000, a 49% increase from 2024.
  • Protara Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $63,000, a 40% increase from 2023.
  • Protara Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $45,000, a 62% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Protara Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $94,000 +$31,000 +49% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $63,000 +$18,000 +40% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $45,000 -$75,000 -62% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2025 2024 FY
2022 $120,000 -$476,000 -80% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
2021 $596,000 -$288,000 -33% 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2023 2022 FY
2020 $884,000 +$409,000 +86% 01 Jan 2020 31 Dec 2020 10-K 09 Mar 2022 2021 FY
2019 $475,000 +$356,000 +299% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
2018 $119,000 +$84,000 +240% 01 Jan 2018 31 Dec 2018 10-K 20 Mar 2020 2019 FY
2017 $35,000 -$236,000 -87% 01 Jan 2017 31 Dec 2017 10-K 13 Mar 2019 2018 FY
2016 $271,000 +$73,000 +37% 01 Jan 2016 31 Dec 2016 10-K 13 Mar 2019 2018 FY
2015 $198,000 +$147,000 +288% 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
2014 $51,000 +$41,000 +410% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2017 2016 FY
2013 $10,000 -$57,000 -85% 01 Jan 2013 31 Dec 2013 10-K 14 Mar 2016 2015 FY
2012 $67,000 01 Jan 2012 31 Dec 2012 10-K 20 Mar 2015 2014 FY

Protara Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $44,000 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2023 $6,000 -$5,000 -45% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $11,000 -$279,000 -96% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $290,000 +$43,000 +17% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $247,000 +$219,887 +811% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $27,113 +$18,113 +201% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q1 2018 $9,000 +$3,000 +50% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $6,000 -$2,000 -25% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q1 2016 $8,000 +$3,000 +60% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $5,000 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.